Maintenance will be taking place on BSI Shop and standards catalogue Wednesday 22 March 2017 between 17:00 – 23:00 GMT. BSI Shop will be unavailable during this time.  Please accept our apologies for any inconvenience caused during this essential maintenance work. Please come back later and try again.

Market Challenges

Key challenge facing this emerging sector include:

  • the segmentation of the market
  • ambiguities in the regulatory framework
  • cautious investor funding
  • ethical considerations concerning the using and sourcing of embryos
  • tissue traceability and donor confidentiality
  • lack of Information about the origins of stem cell therapy
  • intellectual property rights and opportunity costs
  • technical problems faced in going from a tissue sample to the derivation and
  • characterisation of stem cells through to a final product, coupled to unrealistic
  • expectations and “hype”
  • design of clinical studies
  • post-market monitoring
  • compensation and liability for injury.
 Your basket
Your basket is empty